Annual Meeting Archives
2012
Category:
Veterinary: Protein and Peptide Therapeutics for Animal Patients
Institutions:
State Key Laboratory of Long-acting and Targeting Drug Delivery System, Shandong Luye Pharmaceutical Co. Ltd, Yantai
264003, P.R. China; School of Pharmacy, Yantai University, Yantai 264003, P.R. China
264003, P.R. China; School of Pharmacy, Yantai University, Yantai 264003, P.R. China
Category:
Bioactive Materials: Nanomedicines
Institutions:
Departement of Pharmacology and Pharmaceutical Sciences, University of Southern California, 1985 Zonal Ave, Los Angeles, CA 90033
Category:
Bioactive Materials/C&DP: Imaging Diagnostics for Material Characterization
Institutions:
Laboratory of Pharmacotechnology and Biopharmacy, Katholieke Universiteit Leuven, Belgium;Laboratory of Biophysics and Surface Analysis, School of Pharmacy, The University of Nottingham, United Kingdom
Category:
Bioactive Materials: Oral Controlled Release
Institutions:
Pharmaceutical Sciences Laboratory, Department of Biosciences, Åbo Akademi University, Finland; Center of Excellence for Functional Materials, Laboratory of Physical Chemistry, Åbo Akademi University, Finland
Category:
Bioactive Materials: Inorganic Nanosystems
Institutions:
Department of Material Science & Engineering, School of Interdisciplinary Bioscience and Bioengineering, Pohang University of Science and Technology (POSTECH), Kyungbuk 790-784, Korea
Category:
C&DP: Nutraceuticals and Functional Foods
Institutions:
Sensient Pharmaceutical Coating Systems, St. Louis, MO, 63106, USA
Category:
Bioactive Materials: Stem Cell and Regenerative Medicines
Institutions:
TNO, Eindhoven, The Netherlands; Department of Biomedical Engineering, Eindhoven University of Technology, The Netherlands; InGell Labs BV, Groningen, The Netherlands; UMCU, Utrecht, The Netherlands
Category:
Bioactive Materials: Theranostics and Cancer Nanotechnologies
Institutions:
Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, MA 02115
Category:
Bioactive Materials: Theranostics and Cancer Nanotechnologies
Institutions:
Brigham Young University, Provo, Utah, 84602, U.S.A.
2011
Institutions:
Department of Pharmaceutical Sciences, University of Padua, Via F. Marzolo 5, 35131 Padua, Italy gianfranco.pasut@unipd.it
Institutions:
Faculty of Pharmaceutical Sciences and Center for Physical Pharmaceutics, Research Institute for Science and Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan j3b07062@ed.noda.tus.ac.jp
Institutions:
Brown University, Providence, RI, 02903, USA; 2Wayne State University, Detroit, MI, 48201, USA. daniel_cho@brown.edu
Institutions:
Drug Delivery Lab, Biomedical Technology and Device Research Laboratories Industrial Technology Research Institute, Hsinchu, TAIWAN MaggieLu@itri.org.tw
Institutions:
Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, 94158, USA jsw431@gmail.com
Institutions:
Wolfson Centre for Stem Cell, Tissue Engineering and Modelling (STEM), Centre for Biomolecular Sciences, School of Pharmacy, University of Nottingham, NG7 2RD, UK. Paxrg1@nottingham.ac.uk
Institutions:
Development Laboratories, MSD, Hoddesdon EN11 9BU, UK Christian_seiler@merck.com
Institutions:
The University of Nottingham, University Park,Nottingham, NG7 2RD, UK. 2Molecular Profiles Ltd., 8 Orchard Place, Nottingham Business Park, Nottingham, NG8 6PX, UK. pcxcs4@nottingham.ac.uk
Institutions:
Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology, Karl-Franzens Universität Graz, Universitätsplatz 1, 8010 Graz, Austria; Arab International University, Faculty of Pharmacy, Ghabaghib, Daraa, Syria Arab Republic jana.pardeike@uni-graz.at
Institutions:
Massachusetts Institute of Technology, Cambridge, MA, 02138, USA; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, 02129, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA cmjewell@mit.edu
Institutions:
Halozyme Therapeutics, Inc., San Diego, CA 92121 USA dkang@halozyme.com
Institutions:
Programa de Pós-Graduação em Ciências Farmacêucticas / UFRGS, Porto Alegre, RS, 90610-000, Brazil; Programa de Pós-Graduação em Nanotecnologia Farmacêutica / UFRGS, Porto Alegre, RS, 90610-000, Brazil; Instituto de Química / UFRGS, Porto Alegre, RS, 91501-970, Brazil. renatacontri@gmail.com
Institutions:
Centre for Pharmaceutical Nanotechnology, National Institute of Pharmaceutical Education and Research, (NIPER), S.A.S. Nagar (Mohali) Punjab-160062, INDIA sanyogjain@niper.ac.in; sanyogjain@rediffmail.com